Voskaridou, Ersi
University of Milan · University of Campania "Luigi Vanvitelli" · Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · Ente Ospedaliero Ospedali Galliera · Laiko General Hospital of Athens · Azienda Ospedaliera G. Brotzu
3 papers on CoChatORCID 0000-0002-0979-5722
Most cited papers
- Verified
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
Voskaridou, E., Christoulas, D., Bilalis, A., Plata, E., Varvagiannis, K., Stamatopoulos, G., Sinopoulou, K., Balassopoulou, A., Loukopoulos, D., & Terpos, E. (2010) · Blood
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 430
- Verified
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia.
Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., Voskaridou, E., Liew, H.-K., Pazgal-Kobrowski, I., Forni, G. L., et al. (2020) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood transfusion and management
Cited by 332
- Verified
Luspatercept improves hemoglobin levels and blood transfusion requirements in a study of patients with β-thalassemia
Piga, A., Perrotta, S., Gamberini, M. R., Voskaridou, E., Melpignano, A., Filosa, A., Caruso, V., Pietrangelo, A., Longo, F., Tartaglione, I., et al. (2019) · Blood
Hemoglobinopathies and Related DisordersIron Metabolism and Disorders
Cited by 119
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free